Chinese PLA General Hospital
Beijing, Beijing, China, 100853, China
Location status: Recruiting
NCT Number: NCT06449404
This clinical trial study is conducted to detect the imaging characteristics of the patients with Parkinson's diseases (PD) by 7-Tesla (7T) magnetic resonance imaging (MRI).
Interested in participating?
Request Info18 year–80 year
All sexes
Observational
Beijing, Beijing, China, 100853, China
Location status: Recruiting
In this study,we explored the imaging characteristics of PD. First, with the advantage of 7T, we detect the slight changes of PD with short diseases history compared with the healthy. Second, we investigate the different imaging characteristics in subtypes of PD, finding the effective neuroimaging biomarkers to distinguish different subtypes of PD. Finally, we take long time follow-up to evaluate the correlation between the imaging changes and clinical score alteration in PD.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
7T-MRI scaning
Time frame: 5 year after the conduction of clinical trial
The patient's clinical state was evaluated according to the Movement Disorder Society-Unified Parkinson Disease Rating Scale (MDS-UPDRS) and H-Y scale. The former scale total score ranges from 0 to 199, with higher scores indicating more severe symptoms in patients. H-Y scale categorizes PD into five stages with higher stages indicate more severe symptoms.
Comparison will be performed from examinations for case-control study versus for baseline and 5-year follow-up timepoints.
Time frame: 5 year after the conduction of clinical trial
The functional connectivity calculation is primarily based on the BOLD sequence, which is used to describe the degree of connectivity between different brain regions, reflecting the functional activity of the brain. A higher value indicates stronger connectivity and more active function.
Time frame: 5 year after the conduction of clinical trial
The structural metrics calculation is primarily based on the MP2RAGE and DTI sequence, which is used to describe cortical thickness, subcortical nuclei volume, as well as the connectivity of white matter connectivity, respectively. A higher value indicates larger thickness (volume) or stronger connectivity.
Time frame: 5 year after the conduction of clinical trial
Medical records and test data of patients, including demographic characteristics, motor scores, non-motor scores, common comorbidity, hematological analysis, coagulation function, lipids profile, blood biochemistry, were used to construct clinical variables spectrum features. The distribution characteristics of motor symptoms and imaging spectrum features were compared with the multi-dimensional matrix. Gene-imaging association analysis was also used to evaluate the imaging changes.
Contact information is provided by the study sponsor or research team.
Chinese PLA General Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04973423
Calprotectin, Crohn Disease
Amiens, France
View Trial DetailsNCT07071259
Dorsolateral Prefrontal Cortex, EEG
Marseille, France
View Trial DetailsNCT07028476
Automated Dynamic Laximetry (ADL), Care Pathway
Angers, France
View Trial DetailsNCT04106830
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Beijing, Beijing Municipality, China
View Trial Details